TaiRx, Inc. engages in the research and development of novel drug products for cancer treatment. Its products include CVM-118, Rexis, Zelnite, TRX-711, TRX-NOC, TRX-920, and TRX-105. The company was founded by Du Shieng Chien and Yi Wen Chu on August 22, 2011 and is headquartered in Taipei, Taiwan.